𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pseudoprogression in patients with malignant gliomas treated with concurrent temozolomide and radiotherapy: potential role of p53

✍ Scribed by Hyun-Cheol Kang; Chae-Yong Kim; Jung Ho Han; Ghee Young Choe; Jae Hyoung Kim; Jee Hyun Kim; In Ah Kim

Publisher
Springer US
Year
2010
Tongue
English
Weight
214 KB
Volume
102
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Incidence of early pseudo-progression in
Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide
✍ Walter Taal; Dieta Brandsma; Hein G. de Bruin; Jacoline E. Bromberg; Annemarie T πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 128 KB

## Abstract ## BACKGROUND. Radiotherapy (RT) plus concomitant and adjuvant temozolomide (TMZ) is now the standard of care for patients with newly diagnosed glioblastoma. The occurrence of pseudo‐progression directly after RT is a recognized phenomenon, but to the authors' knowledge its incidence a

Prognostic significance of cyclin D1 and
Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy
✍ Eisaku Higuchi; Nobuhiko Oridate; Akihiro Homma; Fumiyuki Suzuki; Yoshihiro Atag πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 2 views

## Abstract ## Background The current study aimed to evaluate the significance of the cell‐cycle‐control proteins cyclin D1 and p16 as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with docetaxel and radiotherapy. ## Methods Cyclin D1 and/or p16 protein exp